ArticleFrontiers in immunology2026

FcRn antagonist and C5 complement inhibitor as early rescue strategies in severe Myasthenia Gravis: a two-case report.

Mosè Parisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.